Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BACKGROUND/AIM: Treatment with growth factors could be beneficial in both inflammatory bowel disease and experimental colitis. The aim of this study was to investigate the effect of Colony Stimulating Factor (CSF), and Recombinant Human (rHu) Granulocyte Stimulating Factor (GSF) in experimental coli...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Papalois, Apostolos E., Barbatis, Calypso, Chrysikos, Dimosthenis, Korontzi, Maria, Sideris, Michail, Pittaras, Theodoros, Triantafyllidi, Eleni, Nomikos, Alexandros, Triantafillidis, John K.
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803744/
https://ncbi.nlm.nih.gov/pubmed/31687401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8298192
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы